Skip to main content

and
  1. Article

    Open Access

    Progression of monoclonal gammopathy of undetermined significance to multiple myeloma is associated with enhanced translational quality control and overall loss of surface antigens

    Despite significant advancements in treatment strategies, multiple myeloma remains incurable. Additionally, there is a distinct lack of reliable biomarkers that can guide initial treatment decisions and help d...

    Sigrid Ravn Berg, Aida Dikic, Animesh Sharma in Journal of Translational Medicine (2024)

  2. Article

    Open Access

    ALKBH3 partner ASCC3 mediates P-body formation and selective clearance of MMS-induced 1-methyladenosine and 3-methylcytosine from mRNA

    Reversible enzymatic methylation of mammalian mRNA is widespread and serves crucial regulatory functions, but little is known to what degree chemical alkylators mediate overlap** modifications and whether ce...

    Kristian Lied Wollen, Lars Hagen, Cathrine B. Vågbø in Journal of Translational Medicine (2021)

  3. Article

    Open Access

    Correction to: HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines

    An amendment to this paper has been published and can be accessed via the original article.

    Tobias S. Iveland, Lars Hagen, Animesh Sharma in Journal of Translational Medicine (2021)

  4. Article

    Open Access

    Impact of HIV-1 Vpr manipulation of the DNA repair enzyme UNG2 on B lymphocyte class switch recombination

    HIV-1 Vpr encodes a 14 kDa protein that has been implicated in viral pathogenesis through modulation of several host cell functions. In addition to pro-apoptotic and cytostatic properties, Vpr can redirect cel...

    Patrick Eldin, Sophie Péron, Anastasia Galashevskaya in Journal of Translational Medicine (2020)

  5. Article

    Open Access

    HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines

    HDAC inhibitors (HDACi) belong to a new group of chemotherapeutics that are increasingly used in the treatment of lymphocyte-derived malignancies, but their mechanisms of action remain poorly understood. Here ...

    Tobias S. Iveland, Lars Hagen, Animesh Sharma in Journal of Translational Medicine (2020)

  6. No Access

    Article

    Novel aspects of macromolecular repair and relationship to human disease

    Cellular and humoral defence mechanisms are essential for the survival of individuals and species. Thus, DNA repair prevents mutations and cytotoxicity from DNA damage, thereby reducing the risks of inappropri...

    Hans E. Krokan, Bodil Kavli, Geir Slupphaug in Journal of Molecular Medicine (2004)

  7. No Access

    Article

    Human uracil–DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination

    Activation-induced cytidine deaminase (AID) is a 'master molecule' in immunoglobulin (Ig) class-switch recombination (CSR) and somatic hypermutation (SHM) generation, AID deficiencies are associated with hyper...

    Kohsuke Imai, Geir Slupphaug, Wen-I Lee, Patrick Revy in Nature Immunology (2003)